Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
771.120.17%
QQQ
716.510.11%
BTC/USD
64814.680.3348%
DIA
543.750.17%
GLD
392.420.71%
TLT
83.050.06%

Usana Health Sciences Inc

USNANYSE
Trade with Public
Trade with Public
$14.99
-7.79-34.20%
At close: Aug 5, 5:00 PM EST
$14.99
N/A
After Hours: 7:34 PM EST
PRO
Why Is It Moving?™:Usana Health Sciences shares are trading lower after the company reported w...
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Usana Health Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Usana Health Sciences (USNA).

Price Target Range — 6 Quarters

Analyst Consensus — 1 Analysts

1Hold
Consensus RatingNeutral# Analysts1Avg. Consensus PT$36Upside to Avg. PT+140.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Feb 27, 2025DA DavidsonLinda Bolton WeiserPT CutNeutral$38→$36
Jan 2, 2025DA DavidsonLinda Bolton WeiserPT RaiseNeutral$35→$38
More with Benzinga EdgeGet Access

Analyst Ratings News

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Friday after closing lower on Thursday’s. Futures of major benchmark indices were higher.
Rishabh Mishra

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $36.
Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $35 to $38.
Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $38 to $35.
Benzinga Newsdesk

Xencor Surges 10.5%: Is This an Indication of Further Gains?

Xencor (NASDAQ: XNCR) shares rallied 10.5% in the last trading session to close at $21.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 19.8% gain over the past four weeks.
Zacks

PRO
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $38

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $46 to $38.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved